We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.32B
AUM Growth
+$155M
Cap. Flow
-$100M
Cap. Flow %
-1.89%
Top 10 Hldgs %
16.3%
Holding
739
New
50
Increased
312
Reduced
249
Closed
35

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$31M
2
CL icon
Colgate-Palmolive
CL
+$20M
3
MRK icon
Merck
MRK
+$18.8M
4
GLW icon
Corning
GLW
+$18.5M
5
FFIV icon
F5
FFIV
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 25.58%
2 Technology 13.62%
3 Financials 13.2%
4 Consumer Discretionary 9.51%
5 Industrials 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEVA icon
251
CEVA Inc
CEVA
$1.01B
$5.07M 0.1%
111,521
+28,475
+34% +$1.17M
DVAX
252
DELISTED
Dynavax Technologies
DVAX
$5.07M 0.1%
+525,000
New +$3.41M
GG
253
DELISTED
Goldcorp Inc
GG
$5.03M 0.09%
390,918
-3,082
-0.8% -$43.1K
NFLX icon
254
Netflix
NFLX
$292B
$5.03M 0.09%
336,550
+19,280
+6% +$297K
SAGE
255
DELISTED
Sage Therapeutics
SAGE
$5.02M 0.09%
63,000
-10,000
-14% -$723K
BWA icon
256
BorgWarner
BWA
$13.2B
$5M 0.09%
134,018
+118,498
+764% +$4.3M
PPG icon
257
PPG Industries
PPG
$25.9B
$4.97M 0.09%
45,243
-2,607
-5% -$282K
CHTR icon
258
Charter Communications
CHTR
$15.2B
$4.96M 0.09%
14,731
-1,075
-7% -$359K
RHI icon
259
Robert Half
RHI
$3.61B
$4.93M 0.09%
102,820
+90,027
+704% +$4.21M
BLK icon
260
Blackrock
BLK
$164B
$4.91M 0.09%
11,620
+1,903
+20% +$759K
IMMU
261
DELISTED
Immunomedics Inc
IMMU
$4.86M 0.09%
550,000
+40,000
+8% +$281K
LXRX icon
262
Lexicon Pharmaceuticals
LXRX
$1.02B
$4.82M 0.09%
293,000
+33,000
+13% +$511K
KSU
263
DELISTED
Kansas City Southern
KSU
$4.8M 0.09%
45,915
-15,716
-26% -$1.47M
NTRS icon
264
Northern Trust
NTRS
$22.2B
$4.75M 0.09%
48,892
+33
+0.1% +$2.97K
HOG icon
265
Harley-Davidson
HOG
$2.68B
$4.73M 0.09%
87,591
-57,383
-40% -$3.19M
KSS icon
266
Kohl's
KSS
$2.03B
$4.72M 0.09%
122,195
+109,104
+833% +$4.18M
PTC icon
267
PTC
PTC
$13.7B
$4.72M 0.09%
85,617
+5,096
+6% +$281K
JWN
268
DELISTED
Nordstrom
JWN
$4.65M 0.09%
97,249
+16,966
+21% +$772K
CPRI icon
269
Capri Holdings
CPRI
$1.77B
$4.63M 0.09%
127,760
-57,511
-31% -$2.09M
AET
270
DELISTED
Aetna Inc
AET
$4.54M 0.09%
29,867
-31,874
-52% -$4.51M
NVR icon
271
NVR
NVR
$17.2B
$4.52M 0.08%
+1,874
New +$4.22M
NKTR icon
272
Nektar Therapeutics
NKTR
$2.39B
$4.52M 0.08%
15,400
+9,067
+143% +$2.62M
ANDV
273
DELISTED
Andeavor
ANDV
$4.52M 0.08%
48,241
+3,389
+8% +$286K
XRAY icon
274
Dentsply Sirona
XRAY
$2.59B
$4.51M 0.08%
69,610
-7,239
-9% -$457K
SPG icon
275
Simon Property Group
SPG
$74.5B
$4.5M 0.08%
27,820
+3,453
+14% +$562K

Similar funds

Candriam SCA's Q2 2017 Portfolio in Review

As of Q2 2017, Candriam SCA held 739 positions worth $5.32B, up 3% from $5.17B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA's Q2 2017 filing shows 50 new, 312 increased, 249 reduced and 35 closed positions. Its largest new stake was Raymond James Financial: 164,790 shares worth $8.81M. The largest sale was PepsiCo, an estimated $40.4M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2017 buy was Raymond James Financial: 164,790 shares worth $8.81M.
  • Candriam SCA added most to Kellanova in Q2 2017, an estimated $31M increase.
  • Candriam SCA's biggest Q2 2017 reduction was PepsiCo, cutting an estimated $40.4M.
  • Candriam SCA fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $20.4M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.32B portfolio in Q2 2017.
  • Candriam SCA opened 50 new positions and closed 35 in Q2 2017.
  • Candriam SCA's portfolio value rose 3% quarter-over-quarter to $5.32B.

Based on Candriam SCA's 13F filing for Q2 2017, filed 31 Jul 2017.